Patents by Inventor Sylvain Cloutier

Sylvain Cloutier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11872376
    Abstract: An injection device for injecting, the injection device comprising a housing having an interiorly facing wall with the wall having a plurality of ribs formed thereon, the ribs defining a channel extending therebetween, a plunger rod mountable within the housing and having at least one protrusion engageable within the channel, a cylindrical body, a spring mounted at a distal end of the housing with the spring being biased between the distal end and a needle hub, and a pusher rod raised such that pressure thereon from the plunger rod will cause the pusher rod to enter the cylindrical body, the pressure causing the spring to act on the needle hub to move the needle hub and the cylindrical body upwardly within the housing such that a needle is in an enclosed position within the housing and cannot be reused.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: January 16, 2024
    Assignee: DUOJECT MEDICAL SYSTEMS INC.
    Inventors: Simon Hamel, Andrea Chagnon, Sylvain Cloutier
  • Publication number: 20230390158
    Abstract: A reconstitution device comprising a cartridge (212) containing a first substance, the cartridge having a plunger (238) at one end and a piercable septum (222) at a second end, a vial (218) containing a second substance, the vial having a piercable septum (224), a housing (210), a cartridge needle hub (226), the cartridge needle hub (226) having a needle (228) protruding therefrom, a vial needle hub (229), the vial needle hub having a needle (222) protruding therefrom, the vial needle hub (229) and the cartridge needle hub (226) being releasably securable together, cartridge latches (240) holding the cartridge needle hub (226) within the housing, vial needle hub latches (231) extending to engage the housing, and a plunger rod (232), the plunger rod having an inner portion (234) engageable with the plunger (238) of the cartridge, the plunger rod (232) having an outer portion (236) which is adapted to engage the vial needle hub latches (240) to release the vial needle hub (229) from engagement with the cartridg
    Type: Application
    Filed: December 21, 2021
    Publication date: December 7, 2023
    Inventors: Mathieu VIENS, Simon HAMEL, Sylvain CLOUTIER
  • Publication number: 20220227638
    Abstract: Titanium dioxide (TiO2) forms the basis of devices for applications including sensing devices, solar cells, photo-electrochromics, and photocatalysis. Such devices exploit different phases of TiO2 within such devices and accordingly it would be beneficial to have an amorphous TiO2 precursor which allows crystalline phase spatial patterning, for the crystallization of the amorphous TiO2 precursor to be triggered at low energies, and with the crystalline phase controllable at room-temperature without necessitating complex handling whilst providing TiO2 phases that ate stable over a prolonged period of time. Accordingly, there ate provided processes for providing a TiO2 precursor and controlling the conversion of the TiO2 precursor from amorphous-to-anatase, amorphous-to-rutile, amorphous-to-mixture of anatase/rutile or from amorphous-to-anatase-to-rutile in a simple and efficient manner.
    Type: Application
    Filed: April 18, 2019
    Publication date: July 21, 2022
    Inventors: JAIME ALBERTO BENEVIDES GUERRERO, CHARLES PHILIPPE TRUDEAU, LUIS FELIPE GERLAIN REYES, SYLVAIN CLOUTIER
  • Publication number: 20210138155
    Abstract: An injection device for injecting an injectable substance, the injection device comprising a housing having an interiorly facing wall with the wall having a plurality of ribs formed thereon, the ribs defining a channel extending therebetween, a plunger rod mountable within the housing and having at least one protrusion engageable within the channel, a vial containing the injectable substance, a spring mounted at the distal end of the housing with the spring being biased between the distal end and the needle hub, and a pusher rod raised such that pressure thereon from the plunger rod will cause the pusher rod to push the injectable substance into the hollow needle for injection, the pressure causing the spring to act on the needle hub to move the needle hub and vial upwardly within the housing such that the needle is an enclosed position within the housing and cannot be reused.
    Type: Application
    Filed: June 19, 2018
    Publication date: May 13, 2021
    Applicant: Duoject Medical Systems Inc.
    Inventors: Simon Hamel, Andrea Chagnon, Sylvain Cloutier
  • Patent number: 10912889
    Abstract: A auto-injector device having a housing (212, 214), a cartridge for containing a medicament, a first needle tip (230) arranged to penetrate said cartridge, a second needle tip (230) for injecting said medicament into a target, said first and second needle tips being in fluid communication, a plunger rod (242) to move said cartridge so as to be pierced by said first needle tip, said plunger rod (242) having a recess (270) in an end thereof, the improvement comprising a battery (258), a printed circuit board (250) electrically communicating with said battery, an electrically conductive element (274) having a first end in electric communication with said battery (258) and printed circuit board (250), a second end within said recess (270) in said plunger rod (242), said second end being electrically insulated, a coil spring (246) surrounding said electrically conductive element and being spaced therefrom, the arrangement being such that when said plunger rod (242) is activated, said second end of said electricall
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: February 9, 2021
    Assignee: Duoject Medical Systems Inc.
    Inventors: Simon Hamel, Sylvain Cloutier, Yan Tremblay, Mathieu Viens
  • Patent number: 10398838
    Abstract: An auto-injector pen has an outer housing (12, 14) which has a proximal end (18) and a distal end (16), an inner housing (84) having a cartridge (74) therein, the cartridge (74) containing a medicament and having one end thereof sealed by pierceable member (80), a needle hub (64) having first and second piercing tips (68, 70) which are in fluid communication, an actuating assembly (28) which moves an actuator from a first position to an activated position wherein the first piercing tip (68) extends outwardly of the outer housing (12,14) at the proximal end (18) and the second piercing tip (70) pierces the pierceable member (80), a first trigger (22) located at the distal end (16) and a second trigger (98) located at proximal end 18, the arrangement being such that the second trigger 98 must be activated to permit activation of the first trigger (22).
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: September 3, 2019
    Assignee: Duoject Medical Systems Inc.
    Inventors: Yan Tremblay, Sylvain Cloutier, Simon Hamel
  • Publication number: 20190192777
    Abstract: A auto-injector device having a housing (212, 214), a cartridge for containing a medicament, a first needle tip (230) arranged to penetrate said cartridge, a second needle tip (230) for injecting said medicament into a target, said first and second needle tips being in fluid communication, a plunger rod (242) to move said cartridge so as to be pierced by said first needle tip, said plunger rod (242) having a recess (270) in an end thereof, the improvement comprising a battery (258), a printed circuit board (250) electrically communicating with said battery, an electrically conductive element (274) having a first end in electric communication with said battery (258) and printed circuit board (250), a second end within said recess (270) in said plunger rod (242), said second end being electrically insulated, a coil spring (246) surrounding said electrically conductive element and being spaced therefrom, the arrangement being such that when said plunger rod (242) is activated, said second end of said electricall
    Type: Application
    Filed: August 25, 2017
    Publication date: June 27, 2019
    Applicant: Duoject MedicalSystems Inc.
    Inventors: Simon Hamel, Sylvain Cloutier, Yan Tremblay, Mathieu Viens
  • Patent number: 9968520
    Abstract: A reconstitution arrangement for transferring the contents of a first container (136) with the contents of a second container (110) and subsequently retransferring the mixture to the first container (136), the arrangement including a transfer device (114) having a fluid passageway extending between first and second ends (111, 113), a cartridge holder (138) secured to second end (113) of the transfer device, the cartridge holder (138) having a needle (144, 145) with first and second piercing tips (117, 119), the first piercing tip (117) extending into the fluid passageway of the transfer device, a first container receiving portion (115) having the second piercing tip (119) extending therein and being arranged to receive the first container (136), a housing (118) secured to the cartridge holder with a plunger rod (122) within the housing, and a cover (130) extending over the transfer device (114), cartridge holder (138) and housing (118), the cover and transfer device having an interlocking arrangement to preve
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: May 15, 2018
    Assignee: Duoject Medical Systems Inc.
    Inventors: Yan Tremblay, Mathieu Viens, Simon Hamel, Sylvain Cloutier
  • Publication number: 20160287788
    Abstract: An auto-injector pen has an outer housing (12, 14) which has a proximal end (18) and a distal end (16), an inner housing (84) having a cartridge (74) therein, the cartridge (74) containing a medicament and having one end thereof sealed by pierceable member (80), a needle hub (64) having first and second piercing tips (68, 70) which are in fluid communication, an actuating assembly (28) which moves an actuator from a first position to an activated position wherein the first piercing tip (68) extends outwardly of the outer housing (12,14) at the proximal end (18) and the second piercing tip (70) pierces the pierceable member (80), a first trigger (22) located at the distal end (16) and a second trigger (98) located at proximal end 18, the arrangement being such that the second trigger 98 must be activated to permit activation of the first trigger (22).
    Type: Application
    Filed: November 17, 2014
    Publication date: October 6, 2016
    Applicant: Duoject Medical Systems Inc.
    Inventors: Yan Tremblay, Sylvain Cloutier, Simon Hamel
  • Publication number: 20160228331
    Abstract: A reconstitution arrangement for transferring the contents of a first container (136) with the contents of a second container (110) and subsequently retransferring the mixture to the first container (136), the arrangement including a transfer device (114) having a fluid passageway extending between first and second ends (111, 113), a cartridge holder (138) secured to second end (113) of the transfer device, the cartridge holder (138) having a needle (144, 145) with first and second piercing tips (117, 119), the first piercing tip (117) extending into the fluid passageway of the transfer device, a first container receiving portion (115) having the second piercing tip (119) extending therein and being arranged to receive the first container (136), a housing (118) secured to the cartridge holder with a plunger rod (122) within the housing, and a cover (130) extending over the transfer device (114), cartridge holder (138) and housing (118), the cover and transfer device having an interlocking arrangement to preve
    Type: Application
    Filed: August 5, 2013
    Publication date: August 11, 2016
    Applicant: Duoject Medical Systems Inc.
    Inventors: Yan Tremblay, Mathieu Viens, Simon Hamel, Sylvain Cloutier
  • Patent number: 9200378
    Abstract: The present invention is directed towards methods for growing diamond nanowires via chemical vapor deposition and apparatuses that incorporate these diamond nanowires.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: December 1, 2015
    Assignee: Brown University
    Inventors: Jingming Xu, Chih-Hsun Hsu, Sylvain Cloutier
  • Patent number: 8975370
    Abstract: The present invention relates to a chimeric inhibitor protein of a protease comprising an inhibiting polypeptidic sequence and at least one polypeptidic sequence of a substrate-enzyme interaction site specific for a protease. Other objects of the invention are to provide a purified and isolated DNA sequence encoding the chimeric inhibitor protein of a protease, an expression vector characterized in that it comprises said purified and isolated DNA sequence, a eukaryotic or prokaryotic host cell transformed with this expression vector and a method of producing a chimeric inhibitor protein.
    Type: Grant
    Filed: April 5, 2004
    Date of Patent: March 10, 2015
    Assignee: Universite de Lausanne
    Inventors: David Deperthes, Sylvain Cloutier
  • Publication number: 20060269536
    Abstract: The present invention relates to a chimeric inhibitor protein of a protease comprising an inhibiting polypeptidic sequence and at least one polypeptidic sequence of a substrate-enzyme interaction site specific for a protease. Other objects of the invention are to provide a purified and isolated DNA sequence encoding the chimeric inhibitor protein of a protease, an expression vector characterized in that it comprises said purified and isolated DNA sequence, a eukaryotic or prokaryotic host cell transformed with this expression vector and a method of producing a chimeric inhibitor protein.
    Type: Application
    Filed: April 5, 2004
    Publication date: November 30, 2006
    Inventors: David Deperthes, Sylvain Cloutier
  • Publication number: 20060233808
    Abstract: The present invention relates to an isolated and recombinant fusion peptabody, which binds to a member of the epidermal growth factor receptor useful in inhibiting the growth of certain tumor cells. Also disclosed are, nucleic acids encoding said isolated and recombinant fusion peptabody, kits and pharmaceutical compositions comprising said isolated and recombinant fusion peptabody as an active substance. Finally, a method for the manufacture of said isolated and recombinant fusion peptabody, and its use for the preparation of a medicament for the treatment or prevention of cancer are provided.
    Type: Application
    Filed: April 5, 2004
    Publication date: October 19, 2006
    Inventors: David Deperthes, Sylvain Cloutier, Jean-Pierre Mach, Nils Holler, Omar Fattah
  • Patent number: 6986828
    Abstract: A process for producing microcrystalline cellulose. The process comprising the following steps: a) preparation of a pulp by repulping, b) pressing of the pulp obtained in a), c) decompaction of the pulp obtained in b), d) feeding of the pulp obtained in c) into a pre-heated reactor, e) cooking of the pulp at a temperature, a time and a pressure allowing to obtain a pulp having a desired degree of polymerization, f) cooling and partial controlled depressurization of the reactor by purging the reactor, followed by a water injection into the jacket and directly into the reactor, g) filtering the pulp obtained in f), h) bleaching of the pulp obtained in g), and i) drying the pulp obtained in h). The process allows the application of a controlled depressurization in step f), which in turn allows to keep the natural texture of the fibers and to obtain a cellulose having a low degree of polymerization.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: January 17, 2006
    Assignee: Kemestrie Inc.
    Inventors: Paul Jollez, Esteban Chornet, Sylvain Cloutier
  • Patent number: 6888624
    Abstract: This invention provides a method of obtaining accurate measurements of polarization dependent loss and insertion loss during the tests aiming at measuring the polarization properties of optical components. This is achieved by taking into account every polarization disturbance in the line between generation of known states of polarization and the device under test. The method involves computing within a desired range of wavelengths either the transfer matrix of each polarization perturbing element or of all polarization perturbing elements as a whole, and compensating for errors introduced by these polarization perturbing elements.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: May 3, 2005
    Assignees: ITF Technologies Optiques Inc., ITF Optical Technologies Inc.
    Inventors: Stéphane Caplette, Sylvain Cloutier, Charles Massicotte, Alain Villeneuve
  • Publication number: 20040007142
    Abstract: An apparatus for treating material, such as lignocellulose material, fibrous material, particulate material, cellulosic material, and the like. The apparatus includes a feed system, a reactor, a conveyor, and a discharge system. The feed system has an inlet for receiving the material from a supply source at ambient pressure conditions and an outlet for releasing the material. The reactor is used for treating the material and has an inlet connected to the outlet of the feed system for receiving the material released from the feed system, and an outlet for releasing the material treated by the reactor. The conveyor is located inside the reactor for conveying the material from the inlet of the reactor to the outlet thereof. The discharge system is used for discharging the material and has a chamber and a pump. The chamber has an inlet connected to the outlet of the reactor for receiving the material treated by the reactor, and an outlet.
    Type: Application
    Filed: May 6, 2003
    Publication date: January 15, 2004
    Applicant: Kemestrie Inc.
    Inventors: Paul Jollez, Sylvain Cloutier
  • Publication number: 20040001202
    Abstract: This invention provides a method of obtaining accurate measurements of polarization dependent loss and insertion loss during the tests aiming at measuring the polarization properties of optical components. This is achieved by taking into account every polarization disturbance in the line between generation of known states of polarization and the device under test. The method involves computing within a desired range of wavelengths either the transfer matrix of each polarization perturbing element or of all polarization perturbing elements as a whole, and compensating for errors introduced by these polarization perturbing elements.
    Type: Application
    Filed: April 7, 2003
    Publication date: January 1, 2004
    Inventors: Stephane Caplette, Sylvain Cloutier, Charles Massicotte, Alain Villeneuve
  • Publication number: 20020084044
    Abstract: A process for producing microcrystalline cellulose.
    Type: Application
    Filed: November 2, 2001
    Publication date: July 4, 2002
    Applicant: KEMESTRIE INC.
    Inventors: Paul Jollez, Esteban Chornet, Sylvain Cloutier